Welcome Guest |   Please Login or Register

News

Surveys Find Key Changes in the Role of the Pharmaceutical CFO
Thursday, March 27, 2008 - 00:25

Views from senior finance executives globally with an in-depth look at perspectives in India
FDA Makes Recommendations on Medical Devices That Treat Blocked Heart Arteries
Thursday, March 27, 2008 - 00:37

ROCKVILLE, Md., March 26, 2008--U.S. Food and Drug Administration Commissioner Andrew C. von Eschenbach
Nature Publishes Study by Santaris Pharma Scientists and Collaborators: LNA-mediated microRNA Silencing in Non-human Primates
Thursday, March 27, 2008 - 00:40

COPENHAGEN, Denmark, March 26th 2008--Santaris Pharma announced today the publication in Nature
FDA MedWatch- Relenza (zanamivir) Changes To The WARNINGS AND PRECAUTIONS Sections Of Prescribing Information For Relenza About Postmarketing Reports Of Neurologic And Behavioral Symptoms
Monday, April 7, 2008 - 22:12

ROCKVILLE, Md., April 2, 2008-GlaxoSmithKline informed healthcare professionals of changes to the WARNINGS AND
Consumer Reports Poll: Most Say TV Drug Ads Should Include Info on How to Report Side Effects
Monday, April 7, 2008 - 22:14

Most Americans Don't Know They Can Report Bad Reactions to FDA Safety Program
Further Data Needed to Determine Risk of Heart Attack with Abacavir
Monday, April 7, 2008 - 22:15

LONDON, April 2, 2008-The European Medicines Agency (EMEA) has looked at data from the D:A:D (‘Data collection of
Connecticut Attorney General Sues U.S. Food And Drug Administration Over Oxycontin
Monday, April 7, 2008 - 22:15

HARTFORD, Conn., March 31, 2008 - Connecticut Attorney General Richard Blumenthal filed a lawsuit in federal court
Takeda Joins the HRP Initiative to Discover Biomarkers of High-Risk Atherosclerotic Plaque
Monday, April 7, 2008 - 22:17

WALTHAM, Mass.--(BUSINESS WIRE)--Apr 1, 2008 - BG Medicine, on behalf of the HRP Initiative, today announced that Takeda
Senator Grassley Asks Merck, Schering-Plough Additional Questions About Vytorin Study
Monday, April 7, 2008 - 22:19

TO: Reporters and Editors
FR: Jill Kozeny, 202/224-1308 for U.S. Senator Chuck Grassley of Iowa
Bayer Appeals Invalidity Ruling on Its Yasmin Patent Appeal Will Be Heard by the Federal Circuit
Monday, April 7, 2008 - 22:20

LEVERKUSEN, Germany, March 31, 2008 - Today, Bayer filed a Notice of Appeal in the United States District Court for the
Zelnorm (tegaserod maleate) Information
Monday, April 7, 2008 - 22:10

$1.5 Billion Annualized Savings Target
KENILWORTH, N.J., April 02, 2008, 2008 /PRNewswire-FirstCall/
Schering-Plough Launches Productivity Transformation Program To Confront New Challenges
Monday, April 7, 2008 - 22:10

$1.5 Billion Annualized Savings Target
KENILWORTH, N.J., April 02, 2008, 2008 /PRNewswire-FirstCall/
Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan
Monday, April 7, 2008 - 21:49

Plan to Include Refocusing of Operations and Workforce Reduction
Pfizer Reports Shares of Encysive Pharmaceuticals Inc. Tendered Pursuant to Guaranteed Delivery Procedures
Monday, April 7, 2008 - 21:51

NEW YORK--(BUSINESS WIRE)--Apr 7, 2008 - On April 1, 2008, Pfizer Inc (NYSE: PFE) announced results of its tender offer by its wholly-owned subsidiary, Explorer Acquisition Corp.,
Novartis to Acquire 25 Percent Minority Stake in Alcon from Nestle
Monday, April 7, 2008 - 21:52

HUENENBERG, Switzerland--(BUSINESS WIRE)--Apr 7, 2008 - Nestle S.A. and Novartis AG announced today that they have reached an agreement pursuant to which Nestle will sell 74 million of its shares of Alcon, Inc.
Forsteo Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis
Monday, April 7, 2008 - 22:01

INDIANAPOLIS, April 4, 2008 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced that the European
Grassley Questions Increases in Drug Maker Rebates to Physicians Prescribing Anti-Anemia Drugs
Monday, April 7, 2008 - 22:03

WASHINGTON April 3, 2008 — Senator Chuck Grassley is asking Amgen Inc. to account for notably high rebates to some
Takeda Wins Definitive Decision in Patent Infringement Litigation on Appeal against an ANDA Filer for Generic Actos
Monday, April 7, 2008 - 22:04

OSAKA, Japan and DEERFIELD , Ill. (April 4, 2008) – Takeda Pharmaceutical Company Limited (“Takeda”) and its
Eisai to Resume Clinical Study to Evaluate E2012 as a Potential Next Generation Alzheimer's Disease Treatment
Monday, April 7, 2008 - 22:06

TOKYO, April 3, 2008-Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) announced that on April 2,
GlaxoSmithKline Confirms Receipt of FDA Letter on Regulatory Reporting
Wednesday, April 9, 2008 - 00:10

LONDON and PHILADELPHIA, April 08, 2008, 2008 /PRNewswire-FirstCall/ -- GlaxoSmithKline today confirmed it